About Lisapharma
Lisapharma is a Healthcare company based in Erba (Italy) founded in 1925, and was acquired by Arcadia SGR in July 2015. Generic sterile injectable products are developed, with contract manufacturing offered. Its chief executive, as recorded, is Massimiliano Del Frate. Lisapharma offers products and services including Sterile Injectable Medicines, Non-Sterile Liquids, Semi-Solid Products, and Medical Devices. Its focus areas include Biopharma Outsourcing, CDMO and Diversified. Its legal entity is LABORATORIO ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA SPA.
Company details
Lisapharma was established in 1925 and is based in Erba, Italy. Operations focus on the pharmaceutical sector, where generic sterile injectable products are developed. Contract manufacturing services are provided for non-sterile liquids, semi-solids, and medical devices spanning multiple therapeutic categories. The company supports various healthcare needs through these activities in the generics industry.
- Headquarters Erba, Italy
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website lisapharma.it/en
- Social LinkedIn
- Acquired by Arcadia SGR (Jul 2015)
- Legal Name Laboratorio Italiano Biochimico Farmaceutico Lisapharma Spa
- Latest Funding Round$58.4K (USD), Grant
Aug 2018
- InvestorsEuropean Union
& 3 more
- Acquired byArcadia SGR
(Jul 2015)
Products & Services of Lisapharma
Lisapharma offers a comprehensive portfolio of products and services, including Sterile Injectable Medicines, Non-Sterile Liquids, Semi-Solid Products, and Medical Devices.
Products for injection produced under sterile conditions.
Liquid formulations for medical applications.
Semi-solid items like creams for therapeutic use.
Devices supporting drug administration and safety.
Funding Insights of Lisapharma
- Total Rounds 2
- Last Round Grant — $58,403
- First Round $61,347
(Mar 2018)
- Investors Count 2
All 2 funding rounds of Lisapharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2018 | $58,403 | Grant | – | – | |
| Mar 2018 | $61,347 | Grant | – | – |
4 investors in total: 4 institutional.
Investors in Lisapharma
Lisapharma has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, EIC Fund and Futurimpresa.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
| futurimpresa.it | ||||
Arcadia SGR is engaged in private equity investments for Italian SMEs. | arcadiasgr.it | Milan, Italy | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Lisapharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Lisapharma
1 people are tracked at Lisapharma (1 in leadership).
| Name | Role | Group |
|---|---|---|
Massimiliano Del Frate | CEO | Leadership |
Complete people profiles for Lisapharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Lisapharma
4 dated milestones of Lisapharma across 93 years, from founding to its latest funding, stage changes and deals.
- Founded Lisapharma is founded.
- Exit Acquired by Arcadia SGR.
- Funding First funding round of $61K.
- Funding Latest funding round, Grant, of $58K.
Web traffic of Lisapharma
The website of Lisapharma (lisapharma.it) receives about 1.6K visits a month.
- Monthly visits1.6K
▲ 123.2% vs previous month
Websites whose visitors overlap most with Lisapharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
static.icmwebserv.com | static.icmwebserv.com | 100% | – | ||
| google.com | 100% | 85.8B | #1 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lisapharma
Lisapharma was founded in 1925 and raised its 1st funding round 93 years after it was founded.
Lisapharma is headquartered in Erba, Italy. It is registered at Erba, Lombardy, Italy.
Massimiliano Del Frate is the CEO of Lisapharma, as recorded in our data.
Lisapharma was established in 1925 and is based in Erba, Italy. Operations focus on the pharmaceutical sector, where generic sterile injectable products are developed. Contract manufacturing services are provided for non-sterile liquids, semi-solids, and medical devices spanning multiple therapeutic categories. The company supports various healthcare needs through these activities in the generics industry.
Lisapharma offers Sterile Injectable Medicines, Non-Sterile Liquids, Semi-Solid Products, and Medical Devices.
Lisapharma has 4 investors. Key investors include European Union, EIC Fund, Futurimpresa, and Arcadia SGR.
Lisapharma operates through Laboratorio Italiano Biochimico Farmaceutico Lisapharma Spa.
Yes. Lisapharma was acquired by Arcadia SGR in July 2015.